Here are a few comparisons from the Drug Trend Reports published by some of the largest PBMs. There is no industry standard on definitions and what is included so I did my best to pick a couple of comparative metrics. (Note: In case you are unfamiliar with these reports, they are summaries of 2007.)
|
Overall Trend |
Specialty Trend |
Managed Trend |
Generic Dispensing Rate |
Mail Order (90-day) |
|
| CVS / Caremark |
4.8% |
13.2% |
2.1% |
59.9% |
28.2% |
| Express Scripts |
4.7% |
14% |
63.7% |
24.1% |
|
| Medco |
2.0% |
12.3% |
59.7% |
38.0% |
|
| Prime Therapeutics |
2.0% |
8.9% |
56.7% |
||
| Walgreens |
4.8% |
(0.07%) |
61.2% |
35.9% |
- CVS/Caremark trend report (TrendsRx 2008)
-
- They break out their best in class as having a 3.4% trend and say that clients who used proactive trend management were at 2.1% on average.
- Best in class generic dispensing rate was 65.6% (employers) and 66.7% (health plans).
- Mail order rate as reported in press release for close of 2007. (Not sure how to compare this to the 12.8% reported in their TrendsRx report.)
-
- Overall trend was 5.5% when specialty drugs are included.
- Had to find the generic fill rate in their 4th quarter financial press release. Either I missed it in the trend report or it was strangely missing.
- Mail order rate was derived from the same 4th quarter release which showed 40.8M mail Rxs and 507M adjusted Rxs. Multiplying 40.8 by 3 to adjust from 90-days to 30-days and dividing that by 507 gave me the 24.1%.
-
- Deriving the mail order rate from the 2007 full year press release gave me 94.8M mail order Rxs which I multiplied by 3 to get to adjusted Rxs and then divided by 748.3M to get 38.0%.
-
Prime Therapeutics trend report (Drug Trend Insights)
- Their trend was 2.9% if specialty drugs are included. Trend ranged from (1.3%) to 7.5% across their blues clients/owners.
-
- Overall trend was 5.66%. The 4.8% excludes specialty trend.
- GDR was 69.6% if you include Medicare.
- The 35.9% mail order rate includes their Advantage90 offering for 90-days at retail.

September 20, 2008 


Trackbacks/Pingbacks
[…] 6.7% of respondents perceived that their benefit costs were increasing more than others and ranked their PBMs lower. (perhaps a validation that trend management matters…hence the “battle” to show the lowest year-over-year trend to the street in the individual trend reports) […]
[…] highlights the drug trend and generic fill rate numbers from the big PBMs (as I have done before). What it made me think about is that with Medco and CVS Caremark having lower generic fill rates, […]